Introduction
Valvular heart disease (VHD) has experienced a dramatic change during the last decades in terms of aetiology and epidemiology. Nowadays, rheumatic aetiology is uncommon in western countries while age-related degeneration has become the main cause of VHD. 1 Although VHD in industrialized countries is not as common as coronary artery disease (CAD) or heart failure (HF) in Europe and North America, 2, 3 it is assuming increasing importance in an ageing population.
Earlier diagnosis as well as continuously developing therapeutic techniques create a challenging panorama to ensure optimal
management of this increasing burden of hospital admissions, interventions, heart failure, reduced functional capacity, and early mortality.
Aortic stenosis (AS) is the most frequent valvulopathy in developed countries as its leading aetiology is calcified-degenerative. 4 Its prevalence has markedly increased as it is higher in elderly population 5 and the life expectancy of citizens of Western societies is steadily growing. Unfortunately, current data about the epidemiology of AS are based on previous studies which have either been retrospective or hospital based, and thus, subject to potential sources of bias. In many cases, series are based in surgical specimens which represent an evident problem when extrapolating results to clinical practice.
Echocardiography plays the main role in the diagnosis of AS. It is an innocuous, reproducible and reliable tool to determine its presence, to evaluate its aetiology and to assess severity. Degenerative, congenital, or inflammatory lesions are readily recognized and their severity graded by this widespread technique.
The present multicentre echocardiographic study aims to provide an accurate and updated analysis of AS, with special interest on its epidemiology, aetiology, mechanisms, and co-existing conditions.
Methods

Study population
Prospective, observational, and multicentre study of consecutive patients referred for an echocardiogram. All patients undergoing an echocardiographic study at 10 hospitals were prospectively included. These 10 hospitals serve a reference population of over 4 565 000 people. All echocardiographic studies, which had a final validated report and had been conducted by an experienced echocardiographer, were considered for inclusion. Subsequently, a total of 29 502 studies were included in a 3-month period between May and July 2016.
Echocardiographic assessment
All echocardiographic examinations were performed according to the recommendations of the European Association of Cardiovascular Imaging. 6, 7 The primary objective was to describe the epidemiology and echocardiographic features of AS. The screening included complete assessment of cardiac chambers, valves, and function. Aortic valve evaluation was performed with two-dimensional echocardiography from the parasternal long axis, short axis, and apical five-chamber view. Standard Doppler measurements of the left ventricular outflow tract (LVOT) and the aortic valve were recorded. Aortic valve area (AVA) was calculated by the continuity equation.
Ventricular and atrial sizes and function were measured using diameters and volumes, and normalized for body surface area (BSA). Mild or more severe left-sided VHD and moderate or severe right-sided VHD were considered as significant concomitant VHD, and were also reported.
AS severity was classified according to 2009 recommendations on the echocardiographic assessment of AS from the European Association of Cardiovascular Imaging and the American Society for Echocardiography. 8 Mild AS was defined as aortic valve thickening or calcification with a maximum transvalvular aortic velocity >2. 5 
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Results
AS was present in 2109 of the 29 502 (7.2%) consecutive echocardiographic studies performed. Frequency of AS among participant centres ranged from 3.1 to 9.7%. Significant (moderate or severe) was found in 1280 (4.3%) patients whereas severe AS was described in 827 (2.8%) studies. Mean age was 75.2 (SD = 10.9) years, and 51.4% of the patients were male. Baseline and echocardiographic characterization are described in Table 1 . The majority of patients with any grade of AS were elders, with the group aged 75 years or more representing 57.7% of all patients. Almost two-thirds (63%) of severe AS corresponded to those patients aged 75 years or more.
Degenerative aetiology was found in 1885 (93.4%) subjects, reflecting the aetiology of AS in the vast majority of patients. This trend was preserved independently of the hospital (see Table 2 Bicuspid valve was present in 141 (7.1%) studies, being these patients, as expected, younger than non-bicuspid AS subjects (mean age 58 years in bicuspid vs. 76 years in non-bicuspid; P < 0.001).
Decreased left ventricular ejection fraction (LVEF) defined as ejection fraction <50%, appeared in 14.1% of the subjects, with almost half (49.3%) of them exhibiting severe AS. Those patients with severe AS and decreased LVEF showed high frequency (44.1%) of low flow and low-gradient pattern.
Left ventricle hypertrophy, defined as left ventricular mass (LVM) indexed to BSA > 95 g/m 2 in females and LVM > 115 g/m 2 in males, was present in most of the patients (72%).
The majority of studies (81.7%) were performed in sinus rhythm. Atrial fibrillation (AF) was found in 15.7% of them, whereas paced rhythm appeared in only a minority (2.6%).
Multivalvular disease was discovered in most studies (49.6%). Any grade of aortic regurgitation (AR) was present in 22% patients with AS, being the most common encountered coexisting valvulopathy. Mitral regurgitation (MR) appeared in 15.6% of patients, tricuspid regurgitation in 11.6%. The less frequent coexisting valvulopathy was mitral stenosis, which appeared in 4.1% of the sample.
Aortic root dilatation (defined as sinus of Valsalva diameter > 34 mm in males, or >30 mm in females) appeared in 702 (28%) of the echocardiographies.
Severe pulmonary hypertension (PHT), defined as pulmonary artery systolic pressure (PSAP) >60 mmHg, appeared in 4.61% of the cases. Relevant proportion (7.6%) of studies showed right ventricle (RV) dysfunction (tricuspid annular plane systolic excursion < _ 16 mm), while RV dilatation (basal diameter >33 mm) was present in 6.4% of patients.
Gender-related differences in severe AS
Males and females with severe AS were compared (see Table 3 ). More than a half of severe AS patients were males (55.7%). Females were older and, as expected, had smaller BSA. No differences were found when comparing indexed AVA, mean transaortic gradient or indexed stroke volume. Chamber size was smaller in female, as also did LVOT and LV indexed mass. Left atrial volume normalized to BSA, was similar between both groups. Rhythm patterns showed no sex-related differences. Rheumatic aetiology, although kept being unusual, was significantly more frequent in females, who also showed higher rates of mitral valve affection regarding both regurgitation and stenosis. RV dysfunction was encountered more frequently in females.
Special subgroups
According to recently published recommendations on the echocardiographic assessment of AS, 9 we analysed the different patterns of flow and gradient in severe cases of AS diagnosed by AVA. We defined paradoxical AS using the following criteria:
• Effective AVA <1.0 cm 2 .
• Mean aortic transvalvular pressure gradient <40 mmHg.
• LVEF <50%.
• Indexed stroke volume <35 mL/m 2 .
In this analysis, subjects with LVEF under 50% were excluded in order to eliminate the potential cause of low flow and gradient that represents systolic dysfunction.
The most common encountered patterns were classical normal flow-high gradient AS (39.5%) and normal flow-low gradient AS (26.3%). An important percentage of patients (24.6%) showed paradoxical LFLG AS, whereas low flow-high gradient AS was the less frequent (9.6%).
A comparison was made between LFLG AS and the rest of severe AS (see Table 4 ). No clinically interesting or statistically significant differences were found in age, gender distribution, AVA or systolic function of left ventricle. Patients with paradoxical AS, showed smaller LV chamber measures, with less grade of left ventricular hypertrophy. AF, mitral and tricuspid regurgitation, and RV dysfunction or dilatation were encountered more frequently in those subjects with LFLG AS.
Backward stepwise multiple logistic regression was performed to determine the factors independently related to the presence of LFLG AS. The final model included AF, MR, RV dysfunction, and LV enddiastolic volume as independent variables associated to the presence of paradoxical AS. Results of the analysis are summarized on Table 5 .
Degenerative AS vs. other aetiologies
Patients with degenerative and non-degenerative AS were compared. Results of this comparison are shown in Table 6 .
Non-degenerative AS appeared more frequently in females, being most of the patients in sinus rhythm, whereas an important percentage of non-degenerative patients presented AF having also higher prevalence of left atrial dilatation (defined as indexed left atrial volume (LAV) > 34 mL/m 2 ). Co-existing valvulopathy was more often described in nondegenerative aetiology, especially mitral stenosis. Severe PHT, (RV) dilatation, and RV systolic impairment were also more frequent in non-degenerative AS.
Discussion
To the best knowledge of the authors, this represents the largest study to analyse the epidemiology of AS in a large cohort of echocardiographic studies performed according to current guidelines with modern technology. This prospective multicentre study is also the first one to provide information of the contemporary aetiology and The epidemiology of heart valve disease has changed during the last decades, and so has done AS. A steady rise in life expectancy has been accompanied by a progressive increase in degenerative valvular disease. However, the real burden of AS nowadays remained unclear. An accurate overall picture of the disease was necessary.
Historical studies on AS epidemiology, 2,3,5,10,11 have either been retrospective or were not conducted in an epidemiologically representative population. Discordant results were found in those studies, presumably due to heterogeneity of samples, and different diagnostic criteria. According to demographic statistics and prevalence rates, 3 the number of subjects aged 75 years or older with at least moderate AS is expected to double over the next 50 years. 12 However, these estimates may be underestimated as they are based in previous studies. Today patients are much older, more fragile and may have multiple comorbidities. 13 A recent population-based study 14 showed an increase in AS prevalence compared with historical series, but did not analyse echocardiographic characteristics, haemodynamic, and aetiological patterns or global repercussion in heart function. In the present sample, composed mainly of elder subjects (almost 60% aged 75 years or more), any grade of AS, was described in more than 7% of the studies, resulting in a frequency that is higher than assumed before. Moreover, significant (moderate or severe) AS appeared more often than in previously cited studies, being almost 3% of the patients diagnosed of severe AS. Haemodynamic severity was more frequent in males, mainly of advanced age (63% aged 75 years or more). These unique data highlight the high burden of AS in a fairly representative sample of the population that receive medical assistance in a national health system. This study confirms that rheumatic AS has become an uncommon diagnosis, whereas degenerative-calcified aetiology represents the vast majority of patients. However, it must be noted that nondegenerative severe AS, appears in earlier ages, and often presents echocardiographic findings, such as PHT or RV dysfunction, that reflects advanced stage of their disease and poor prognosis. These results involve widespread implications for clinicians and healthcare resources.
Previous studies focused on AS sex-related aspects, 15, 16 showed striking differences in terms of gender distribution. Our study, according to Thaden et al., 15 describes higher prevalence of male sex among those subjects with severe AS. Females were, as reported before, 16 older than males. Regarding to haemodynamic assessment of severity, we found no differences in indexed AVA, mean systolic gradient of normalized SV. Smaller left ventricular chamber was encountered in females, where LVOT was also reduced when compared with males. These data, according to the absence of differences in MG, indexed AVA or indexed SV might be in relation to smaller heart size rather than different remodelling patterns. Interestingly, rheumatic aetiology, although is an uncommon diagnosis, appears more frequently in females, who also showed significant higher prevalence of coexisting valvulopathy, especially mitral valve affection. Multivalvular disease could explain an increased proportion of RV dysfunction that was observed in females.
In the present sample, paradoxical LFLG AS appeared in almost a quarter of patients (24.6%), being this prevalence an intermediate value among previously reported data. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] As reported in the original description of paradoxical LFLG-AS 18 patients presenting paradoxical AS showed more frequently AF, smaller LV chamber size and indexed LV mass, in relation to more pronounced concentric remodelling. Through impaired LV filling or increased heart rate, AF may contribute to low flow and low gradient. Consequently, AF, which has been reported in up to 51% of LFLG patients, 30 may lead to misclassification of some patients. Our study shows lower, but still high, prevalence of AF in this group with paradoxical AS when compared with the rest of severe AS. Reverse flow direction due to significant MR and a decrease in LV preload in the context of RV dysfunction might explain that both variables (MR and RV dysfunction) were also found to be independently associated to the presence of paradoxical AS.
Prognosis of paradoxical AS remains controversial. Although this pattern of disease has traditionally been linked to poor prognosis and outcomes, 18, 23, [28] [29] [30] recent studies have reported that LFLG AS carries better prognosis than conventional normal flow-high gradient severe AS. 22 Such discrepancy might be attributable to differences in baseline characteristics of the studied samples, comorbidities, and concomitant valvular disease. Although our study lacks long-term clinical follow-up, patients with paradoxical AS did not show echocardiographic findings (such as increased LAV, or PSAP) suggestive of a more advanced stage of their disease when compared with the rest of severe AS patterns.
Limitations
This is not a population-based study, with the potential selection bias of recruiting individuals with cardiac symptoms, or heart murmur discovered within a routine examination. This may have overestimated the burden of AS. However, since AS diagnosis depends on echocardiographic evaluation, we believe that this sample fairly represents the true population of AS subjects who receive medical assistance.
Conclusions
The present study is the first one aimed to establish the current burden of AS in a large cohort of consecutive echocardiographic exams. Moreover, the present study, shed light about aetiology, patterns of severity and echocardiographic features of AS. AS is a common finding, and a prevalent condition among subjects undergoing echocardiographic evaluation. Severe AS appears more frequently in males of advanced age. In terms of haemodynamic repercussion, severe AS does not present different sex-related behaviour.
Degenerative aetiology represents the vast majority of AS cases. Rheumatic aetiology, which years before was an important cause of AS, is nowadays infrequent. However, it appears in medium-age adults, preferably females, and is still related to important echocardiographic signs of haemodynamic impairment.
LFLG-AS appears in an important proportion of patients with severe AS. Patients suffering from LFLG-AS often present with AF and coexisting valvular disease. AF, MR, and RV dysfunction are potential causes of low flow and low gradient that are independently associated to the diagnosis of paradoxical AS. Although LFLG-AS prognosis remains unclear and despite no follow-up was performed during this study, our data suggest that LFLG-AS consists on intensely remodelled ventricles, but with no echocardiographic findings suggesting a more advanced stage of their disease.
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